Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

CONSORT 2025 Flow Diagram [70]. by Robert Trybulski (10998702)

“…Time to peak and recovery time were longest in the standing position (p = 0.003–0.009). HRV analyses revealed a significant decrease in AVNN from supine to sitting and standing (p = 0.003), while SDNN and LF/HF increased in upright positions (sitting and standing) (p < 0.013). …”

Fig 16 - by Zhezhe Zhang (19704587)

Fig 25 - by Zhezhe Zhang (19704587)

Fig 9 - by Zhezhe Zhang (19704587)

Fig 24 - by Zhezhe Zhang (19704587)

Fig 15 - by Zhezhe Zhang (19704587)

Fig 23 - by Zhezhe Zhang (19704587)

The relationship between residual shear strength and <i>JRC</i>, normal stress. by Zhezhe Zhang (19704587)

OKIO 3D scanner, 3D views of the fracture surfaces and selection of section line. by Zhezhe Zhang (19704587)

Fig 28 - by Zhezhe Zhang (19704587)

Fig 17 - by Zhezhe Zhang (19704587)

The relationship between pre-peak shear stiffness and <i>JRC</i>, normal stress. by Zhezhe Zhang (19704587)

Fig 10 - by Zhezhe Zhang (19704587)

Fig 19 - by Zhezhe Zhang (19704587)

Fig 8 - by Zhezhe Zhang (19704587)

Fig 20 - by Zhezhe Zhang (19704587)

Fig 26 - by Zhezhe Zhang (19704587)

Fig 5 - by Zhezhe Zhang (19704587)

DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”